Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy

New England Journal of Medicine

Volumn 372, Issue 11, 2015, Pages 1073-1075

  Gödel, Markus ^a   Grahammer, Florian ^a   Huber, Tobias B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PHOSPHOLIPASE A2 RECEPTOR; THROMBOSPONDIN 1; THROMBOSPONDIN TYPE 1 DOMAIN CONTAINING 7A; UNCLASSIFIED DRUG; AUTOANTIBODY; THROMBOSPONDIN;

HUMAN; IMMUNOGOLD LABELING; LETTER; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; BLOOD; IMMUNOLOGY;

AUTOANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; RECEPTORS, PHOSPHOLIPASE A2; THROMBOSPONDINS;

EID: 84924675239     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1500130     Document Type: Letter

References (3)

1. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361:11-21.
2. Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014;371:2277-87.
3. Boerries M, Grahammer F, Eiselein S, et al. Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int 2013;83:1052-64.